SCHEMBL6943335

SCHEMBL6943335

CC(C)[C@@H](CCO)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.55
CYP4A11 Q02928 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.52
KMT2A Q03164 2/20 0.52
BCHE P06276 1/20 0.51
MEN1 O00255 1/20 0.51
ALOX5 P09917 1/20 0.51
MAOB P27338 4/20 0.50
RRM1 P23921 1/20 0.48
SGMS2 Q8NHU3 1/20 0.47
NR4A2 P43354 1/20 0.47
TSHR P16473 2/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11159586 0.86 CYP4F2 (0.57) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL9577515 0.82 CYP4F2 (0.59) CYP4F2CYP4A11SMN1; SMN2KMT2AMEN1
SCHEMBL3972720 0.81 SMN1; SMN2 (0.69) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL28969175 0.80 BCHE (0.59) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL20604383 0.80 KMT2A (0.62) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL24646088 0.80 BCHE (0.59) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL28969207 0.80 BCHE (0.59) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL20604382 0.80 KMT2A (0.62) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL30313797 0.80 BCHE (0.59) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE
SCHEMBL30312294 0.80 BCHE (0.59) CYP4F2CYP4A11SMN1; SMN2KMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1266118-C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides NOVARTIS AG (CH) 2006-07-26 CN disclosed
CN-1550491-A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides ��˹��ŵ�� 2004-12-01 CN disclosed
CN-1153759-C Novel delta-amino-gamma hydroxy-omega-aryl-alkanamides ��˹��ŵ�� 2004-06-16 CN disclosed
WO-2003103653-A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed
CN-1117960-A Novel delta-amino-gamma hydroxy-omega-aryl-alkanamides CIBA GEIGY AG (CH) 1996-03-06 CN disclosed